Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Raymond James Maintains Outperform on Alphabet, Raises Price Target to $3400

Raymond James analyst Aaron Kessler maintains Alphabet (NASDAQ:GOOG) with a Outperform and raises the price target from $3200 to $3400.

byBenzinga Newsdesk

October 27, 2021

1 minute read

Raymond James analyst Aaron Kessler maintains Alphabet (NASDAQ:GOOG) with a Outperform and raises the price target from $3200 to $3400.

Belite Bio Seeks FDA Clearance For Late-Stage Genetic Eye Disease Study

By Ragothaman Srinivasan

July 19, 4:32 PM

Belite Bio (NASDAQ: BLTE) submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to support Phase 3 development of its lead asset LBS-008 for treatment of Stargardt Disease (STGD1).

BLTE

USA Business Inventories (MoM) for Mar 2.000% vs 1.900% Est; Prior 1.500%

By Benzinga Newsdesk

May 17, 10:00 AM

USA Business Inventories (MoM) for Mar 2.000% vs 1.900% consensus estimate. The prior reading was 1.500%.

SPY

Gaotu Techedu Earlier Reported Q2 Sales $80.29M Miss $107.15M Estimate

By Benzinga Newsdesk

September 8, 6:40 AM

Gaotu Techedu (NYSE:GOTU) reported quarterly sales of $80.29 million which missed the analyst consensus estimate of $107.15 million by 25.07 percent. This is a 76.78 percent decrease over sales of $345.73 million the

GOTU